Martijn van Gerven joins keynote panel at World AMR Congress 2024

The World AMR Congress 2024 is one of the leading global events focused on antimicrobial resistance (AMR), attracting up to 1,300 attendees, including policymakers, hospital leaders, and representatives from antibiotic biotechs and pharmaceutical companies. The gathering offers opportunities to engage in conversations around One Health, vaccine accessibility and strategies to combat the rise of drug-resistance.

Martijn will participate in a panel discussion, titled "Putting AMR on the global agenda: Setting targets, accelerating action, and ensuring accountability.” He joins other expert across global health, including: 

• Cecilia Mundaca Shah, Senior Director, Global Health, United Nations Foundation 

• Jennifer Young, Vice President, Global Policy and Public Affairs - Specialty Care, Policy Planning & Strategy, Pfizer 

• Jeremy Knox, Head of Policy, Infectious Diseases, Wellcome Trust 

Utilising his expertise in AMR, Martijn will convey the importance of pharmaceutical companies’ continued, active and long-term engagement in helping to curb this global health threat. In doing so, he will cite key takeaways from research by the AMR Programme, including its recently published research and development paper, which focuses on how companies can engage in advance access and stewardship planning to ensure newly developed antibiotics and antifungals reach patients who need them most. In addition, he will discuss the five priorities companies need to keep front of mind in the battle against AMR, which were included in a briefing document prepared by the Foundation ahead of the United Nations General Assembly (UNGA) High-level Meeting on AMR in September.  

During the event, Martijn will also share more information on the upcoming AMR Benchmark Methodology, which is currently being developed by the Foundation. Representatives from pharmaceutical companies in attendance will find this particularly useful in gaining insights on antimicrobial R&D, responsible manufacturing, and access and stewardship planning.